Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Ivermectin Potential treatment - clinical evidence Used to treat other disease Antiviral Mar/30/2021 17 2
Itraconazole Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/20/2021 2 1
Tocilizumab Recommended by China's NHC Guidelines Used to treat other disease Other treatment Mar/19/2021 81 18
GC376 Potential treatment - pre-clinical evidence Experimental Antiviral Mar/19/2021 10 0
Hydroxychloroquine sulfate Potential treatment - clinical evidence Used to treat other disease Antiviral Mar/08/2021 40 43
Heparin Potential treatment - clinical evidence Used to treat other disease Antiviral Jan/22/2021 12 1
Interferon alfa-2b Potential treatment - clinical evidence Used to treat other disease Antiviral Dec/30/2020 2 0
U18666A Potential treatment - pre-clinical evidence Experimental Antiviral Nov/25/2020 1 0
25-hydroxycholesterol  Potential treatment - pre-clinical evidence Natural product Antiviral Nov/25/2020 3 0
Baricitinib Emergency use authorization Used to treat other disease Other treatment Nov/13/2020 6 0